Let's talk medical research

Celiac disease, an autoimmune disorder that causes a reaction to gluten, is a condition that impacts about 1 in 141 people in the United States. For those with celiac disease, ingesting gluten creates toxins that destroy the villi of the small intestine, which makes it difficult for the body to absorb nutrients from food.

Gaining insight into medical conditions is what clinical trials are all about, but the data acquired is inevitably specific to the study participants — and in many cases, this means that racial and ethnic minorities are underrepresented in the results. Conducting medical studies is vital to discovering new therapies for conditions, but to do this effectively, researchers must ensure that their ...

Recruiting an adequate number of qualified participants is one of the most important aspects of a successful clinical trial — but it is also considered one of the most difficult. Clinical trial recruitment costs make up a major portion of the expenses that study sponsors incur, and when trials have to be delayed due to a lack of participants, each day of the setback can cost sponsors between ...

Across all genders and ethnic groups, cardiovascular disease is the leading cause of death in the United States. It is estimated that 8.8 million adults above age 20 have had a heart attack, and 7.6 million have had a stroke. These events can occur for many reasons, but a lesser-known risk factor is elevated lipoprotein(a) (Lp(a)).

At Antidote, we understand that it can be difficult for patients to discover how to participate in clinical trials — which is why creating a patient-centric user experience for our clinical trial search tools is one of our main priorities.

Medical research is how new treatments and therapies move forward, but challenges surrounding patient recruitment can often lead to delays. Patients often have misconceptions about participating in a clinical trial — and if they are interested, they often aren’t sure where to begin.

Mitral valve regurgitation is a common kind of heart disease in the United States. Not only does it impact many people today, but its prevalence is expected to double by 2030.

Complement 3 glomerulopathy (C3G) is a rare type of kidney disease, estimated to impact just 1 to 2 million people worldwide. C3G is a genetically inherited disorder that impacts all races and genders equally, and the average patient is diagnosed between the ages of 21 and 26.

The process of getting a new drug to market is an expensive one. Between 2009 and 2018, U.S. biopharmaceutical companies spent about $1 billion per drug according to an analysis published in JAMA, and other studies have found that it can cost up to $2.8 billion to bring a new therapy to market. In 2019 alone, research and development spending totaled $186 billion for the global pharmaceutical ...

Alexis Smith had eczema as an infant, but had lived a mostly itch-free childhood until hitting puberty at 12. That's when her symptoms came back.